imipramine has been researched along with Cardiac Death in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HNATKO, SI | 1 |
STIRRAT, JH | 1 |
VERCHOMIN, J | 1 |
RAMSEY, CG | 1 |
NOACK, CH | 1 |
2 other studies available for imipramine and Cardiac Death
Article | Year |
---|---|
AGRANULOCYTOSIS ASSOCIATED WITH IMIPRAMINE (TOFRANIL).
Topics: Agranulocytosis; Blood Chemical Analysis; Death; Drug Therapy; Imipramine; Leukocyte Count; Phenothi | 1965 |
A death from overdosage of "tofranil".
Topics: Death; Death, Sudden; Drug Overdose; Humans; Imipramine; Medical Records; Psychopharmacology | 1960 |